Total revenues for Q4 2025 were $57.6 million, with Vafseo net product revenues at $6.2 million and Auryxia net product revenues at $48.1 million. Net loss in Q4 2025 was $12.2 million. Cash and cash ...
B. Braun, one of the world’s leading healthcare and medical technology companies.Through this collaboration, B. Braun ...
As of Tuesday, February 24, Fresenius Medical Care AG’s FMS share price has dipped by 6.71%, which has investors questioning ...
HATTIESBURG, Miss. (WDAM) - It was Christmas 2024 when Willis Preston, 58, heard a voice. “He started having his toes giving ...
Latin Times on MSN
El Mencho Wasn't Able To Constantly Change Locations Because He Had a Late-Stage Kidney Disease: Report
Ruben Nemesio Oseguera Cervantes, known as "El Mencho" and longtime leader of the Cartel Jalisco Nueva Generacion, wasn't ...
Territorian teacher Chris Blackham-Davison was in the middle of a five-hour hospital dialysis session in January when he got ...
Shreveport faces a potential week-long water crisis after an old 42-inch main broke, causing low pressure. Caddo Schools ...
The aftermath of a Mexican special forces raid that killed the notorious leader of the Jalisco New Generation cartel offered ...
Now that the head of the Jalisco New Generation cartel is dead, what will happen to its coalition of ruthless regional ...
HRTLY welcomes Dr. Beena Peters and Brittany Leach, seasoned leaders advancing clinical strategy, governance, and ...
TD Cowen 46th Annual Health Care Conference March 2, 2026 11:50 AM ESTCompany ParticipantsJoel Ackerman - CFO & ...
Study findings may motivate healthcare stakeholders, employers, and policymakers to initiate programs and policies to support transplant recipients in return to work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results